openPR Logo
Press release

Myelodysplastic Syndrome Treatment Market Trends and Prospects by 2025

04-11-2018 03:51 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Myelodysplastic Syndrome Treatment Market Trends

Myelodysplastic Syndrome Treatment Market: Overview

Myelodysplastic syndrome (MDS) is a blood disorder caused due to the production of abnormal blood cells in bone marrow. Bone marrow failure leads to drop in the number of healthy blood cells in the body. In MDS, bone marrow does not produce healthy red blood cells, white blood cells, and/or platelets. Symptoms of MDS in the beginning are no specific than causes of pancytopenia i.e., deficiency of RBC, WBC and platelets. Therefore, the final diagnosis of MDS is done after examination of the cells of bone marrow. Bone marrow sample is taken from inside of a bone (usually the hip bone) and examined with a microscope using special stains to look for abnormal and immature cells. According to the American Cancer Society, over 13,000 new cases of MDS occur in the U.S. each year. According to the National Organization for Rare Disorders, 30% of patients with MDS can develop a form of blood cancer known as acute myeloid leukemia. Majority of patients diagnosed with MDS are aged between 65 and 70; however, MDS can affect people of any age and the risk of developing MDS increases with age.

Download PDF Brochure of Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34073

The global myelodysplastic syndrome treatment market is driven by rise in the global geriatric population as MDS is most commonly found in this population and remains an incurable disease. Moreover, significant progress has been made in the diagnosis of MDS with the help of sequencing technologies. Chromosomal abnormalities can be identified in MDS patients with these technologies. These are useful for both diagnosis and prognosis in MDS patients. For instance, patients with chromosome 5q deletions are more likely to respond to lenalidomide. No new drugs have been approved for MDS by the U.S. Food and Drug Administration since 2006. Current available therapies can be efficacious, but are generally not curative. Some of the challenges in developing new treatments are the complexity and heterogeneity of MDS as a disease.

The global myelodysplastic syndrome treatment market can be segmented based on type of treatment and region. In terms of type of treatment, the market can be classified into supportive therapy, growth factors, chemotherapy (including hypomethylating agents), and stem cell transplant. Cytarabine, azacitidine, decitabine, and lenalidomide are the major drugs used during chemotherapy. Stem cell transplant is the only cure for MDS; however, majority of patients are not treated with stem cell transplant due to various factors such as high treatment cost, transplant-related deaths, and relapse rate at five years (as high as 40%). The chemotherapy segment is expected to hold major share of the global myelodysplastic syndrome treatment market due to larger application and less complications than other therapies such as stem cell transplant.

Request to View TOC of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34073

Geographically, the global myelodysplastic syndrome treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. North America is projected to dominate the global myelodysplastic syndrome market during the forecast period due to factors such as the rise in aging population and growing awareness about the disease among the population coupled with unmet medical needs in this region.

Key players operating in the global myelodysplastic syndrome treatment market are Celgene Corporation, Otsuka Holdings Co., Ltd., Sandoz, Inc., Dr. Reddy's Laboratories, Inc., Accord Healthcare Ltd., Mylan N.V., and Pfizer, Inc.

Request to View Discount –

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=34073

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

More Trending Reports by Transparency Market Research:

Surgical Tables Market:

https://globenewswire.com/news-release/2018/02/28/1401258/0/en/Surgical-Tables-Market-to-be-worth-US-1-014-3-Million-by-2022-Transparency-Market-Research.html

Diabetes Drugs Market:

https://globenewswire.com/news-release/2018/03/05/1414894/0/en/Diabetes-Drugs-Market-to-be-worth-US-58-4-Billion-by-2025-Transparency-Market-Research.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myelodysplastic Syndrome Treatment Market Trends and Prospects by 2025 here

News-ID: 1012436 • Views: 206

More Releases from Transparency Market Research

Electromechanical Microwave Switch Market To receive overwhelming hike in Revenu …
Transparency Market Research delivers key insights on the global electromechanical microwave switch market. Get Report Details- https://www.transparencymarketresearch.com/electromechanical-microwave-switch-market.html In terms of revenue, the global electromechanical microwave switch market is estimated to expand at a CAGR of ~5% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the global electromechanical microwave switch market. Grab an Exclusive PDF Sample of this Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82213 Electromechanical Microwave
Emerging trends of the High Reliability Semiconductor Market 2021-2031
Transparency Market Research delivers key insights on the global high reliability semiconductor market. In terms of revenue, the global high reliability semiconductor market is extended to expand at a CAGR of ~5% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in its report on the global high reliability semiconductor market. Get Report Details- https://www.transparencymarketresearch.com/high-reliability-semiconductors-market.html The global high reliability semiconductor market is broadly affected by
DUV Lithography Systems Market Pegged for Robust Expansion During 2021-2031
The COVID-19 crisis has led to a shortage of semiconductor products, owing to a slowdown in production activities. Nevertheless, changing consumer habits are grabbing the attention of companies in the DUV lithography systems market, pertaining to the demand for gaming consoles, TVs, and 5G-enabled smartphones, among others. Get More Report Details- https://www.transparencymarketresearch.com/duv-lithography-systems-market.html On the other hand, the electrification of vehicles is anticipated to generate great future revenue opportunities for manufacturers in the
Electronic Potting & Encapsulating Market To Register Substantial Expansion By 2 …
Potting is the process of filling a complete electronic assembly with a solid or gelatinous compound such as acrylic, silicone, or resins. Potting provides resistance to vibration and shocks. It also offers protection from corrosive agents and moisture. Report Details- https://www.transparencymarketresearch.com/electronic-potting-encapsulating-market.html Encapsulation forms a frame around an object and fills the space between the frame and the object with compounds by using a reusable mold. The key purpose of encapsulation is to

All 5 Releases


More Releases for MDS

Healthcare M2M Market to See Huge Growth by 2025 | Athenahealth, McKesson, Amazi …
The Latest research study released by HTF MI “Global Healthcare M2M Market” with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research
Myeloidysplastic Syndromes (MDS) – Epidemiology Insights (2016-2028)
Myeloidysplastic syndromes (MDS) can be described as a group of hematologic malignancies, that occurr due to abnormality in blood-forming cells in the bone marrow. It is a rare blood cancer and can be mild, moderate or severe, in terms of severity. Download the sample report @ https://www.pharmaproff.com/request-sample/1162 This syndrome can be classified into three main types: MDS with single lineage dysplasia wherein a single type of blood cell appears abnormal; multilineage
Top Scenario: Healthcare CRM Market By Key Players: Allscripts, Cerner, e-MDs, C …
Qyresearchreports include new market research report Healthcare CRM to its huge collection of research reports. Healthcare CRM, also known as Healthcare Relationship Management, is a broadly used term for a Customer relationship management system In 2017, the global Healthcare CRM market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global
Myelodysplastic Syndrome (MDS) Treatment Market Industry Forecast till 2025
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more
Global Myelodysplastic Syndrome (MDS) Therapeutics Market Size, Trends, Analysis …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “2018-2025 Report on Global and United States Myelodysplastic Syndrome (MDS) Therapeutics Market Status and Forecast, by Players, Types and Applications” which provides an outlook of current market growth as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR near XX% during 2018-2025. The report studies myelodysplastic syndrome therapeutics in global market,
Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Insights 2025
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around